Patent application number | Description | Published |
20080305050 | Analysis of P. aeruginosa infection in patients - The present invention relates to methods for detecting | 12-11-2008 |
20090191639 | Non-Invasive Rapid Diagnostic Test For M.Tuberculosis Infection - This invention relates to a test for detecting a | 07-30-2009 |
20110021623 | SYSTEM AND METHODS OF MELANOMA PREVENTION - Inhibiting the enzymic action of tyrosinase in the melanocyte prior to, during, or after ultraviolet (UV) radiation exposure, including over-exposure causing erythema, or sunburn, prevents the production of melanin and thereby melanoma. Melanoma can be prevented by using a tyrosinase inhibitor agent that inhibits the enzymic action of tyrosinase to prevent damage and/or death of melanocytes. The inhibitor agent can be applied to the skin or ingested. | 01-27-2011 |
20110218220 | RATIONALLY IMPROVED ISONIAZID AND ETHIONAMIDE DERIVATIVES AND ACTIVITY THROUGH SELECTIVE ISOTOPIC SUBSTITUTION - The present invention relates to the use of isotopically labeled derivatives of isoniazid, ethionamide and related compounds as effective therapy for the treatment of mycobacterial diseases, including | 09-08-2011 |
20130150415 | RATIONALLY IMPROVED ISONIAZID AND ETHIONAMIDE DERIVATIVES AND ACTIVITY THROUGH SELECTIVE ISOTOPIC SUBSTITUTION - The present invention relates to the use of isotopically labeled derivatives of isoniazid, ethionamide and related compounds as effective therapy for the treatment of mycobacterial diseases, including | 06-13-2013 |
20140212916 | RAPID TEST FOR DETECTION OF INFECTION AND THERAPEUTIC RESPONSE - The present invention is directed to the use of isotopically labeled citrulline for gnosing the presence or absence of a bacterial infection in the lungs of a patient. | 07-31-2014 |
20140314737 | Blood Biomarker for Early Blood Brain Barrier Disruption in Ischemic Stroke - Methods and apparatus for determining blood brain barrier (BBB) damage and treating patients who may have suffered from BBB damage due to an ischemic event are provided. The methods and apparatus involve detecting the presence of cleaved occludin fragments in a sample of blood. According to some embodiments, the method further provides determining the degree of BBB damage based on the concentration of occludin fragments in the sample. In further embodiments the present disclosure provides kits for detecting the presence of occludin fragments in a blood sample. | 10-23-2014 |
20150104819 | METHODS OF USING ISONIAZID FOR THE DIAGNOSIS OF LUNG INFECTIONS - The present invention is directed to methods of diagnosing the presence or absence of a bacterial infection in a patient, in particular, a tuberculosis infection, by measuring exhaled, isotopically labeled nitrogen gas after administration of isotopic ally labeled isoniazid. | 04-16-2015 |